This inventor holds 6 USPTO granted patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2004-2024.
Location History:
- Bethesda, MD (US) (2004 - 2008)
- Kensington, MD (US) (2017 - 2024)
Company Filing History:
Years Active: 2004-2024
Title: Andrzej Grajkowski: Innovator in Nucleic Acid Synthesis
Introduction
Andrzej Grajkowski is a notable inventor based in Kensington, MD (US), recognized for his contributions to the field of nucleic acid synthesis. With a total of 6 patents to his name, he has made significant advancements that enhance the efficiency and effectiveness of nucleic acid production.
Latest Patents
Grajkowski's latest patents include innovative methods and solid supports for synthesizing nucleic acid sequences. One of his key inventions is a solid support designed for synthesizing nucleic acid sequences, which features a structure based on controlled pore glass (CPG). This invention outlines methods for creating and utilizing the solid support, along with kits that incorporate it and a universal linker phosphoramidite. Another significant patent focuses on the solid-phase purification of synthetic nucleic acid sequences, providing a method to purify oligonucleotides from mixtures, thereby improving the quality of nucleic acid products.
Career Highlights
Andrzej Grajkowski works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His work has been pivotal in advancing the methodologies used in nucleic acid synthesis and purification, contributing to various applications in biotechnology and medicine.
Collaborations
Grajkowski has collaborated with esteemed colleagues such as Serge L Beaucage and Andrzej Wilk, further enhancing the impact of his work in the scientific community.
Conclusion
Andrzej Grajkowski's innovative contributions to nucleic acid synthesis and purification underscore his importance in the field. His patents reflect a commitment to advancing biotechnology, making significant strides in the efficiency of nucleic acid production.